Remove Packaging Remove Research Remove Seminar
article thumbnail

Article EMA Thank You What we expect European regulators to do in November 2023

Agency IQ

Upcoming Webinar Hosted by Xtalks Webinar/Seminar ( OPEN) Xtalks 11/6/2023 11/6/2023 What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?

article thumbnail

Article EMA Thank You What we expect European regulators to do in June 2024

Agency IQ

Even small changes in the Parliament’s composition could have an impact on ongoing legislative discussions, such as the revisions to the pharma reform package. The current European Parliament and Commission have confirmed their position on the pharma package, but the European Council is still working on its negotiation position.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article EMA Thank You What we expect European regulators to do in May 2024

Agency IQ

The pharma reform package remains in E.U. In the interim, the European Council will continue to discuss the package, and stakeholders may gain some insight into the Council’s thinking near the end of May. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. On April 10, the E.U.

article thumbnail

Article EMA Thank You What we expect European regulators to do in August and September 2024

Agency IQ

Another legislative area that will also likely receive more attention will be the pharma reform package , since the two Parliament rapporteurs to lead the package negotiations were recently appointed.

article thumbnail

New insights into the role of viral capsids in gene therapy safety

Drug Target Review

Among them, adeno-associated viruses (AAVs) stand out due to their small size, high efficiency in gene delivery, low immunogenicity, and potential for customisable tissue targeting, making them the leading tool in gene expression research.

article thumbnail

Analysis Life Sciences Thank You FDA fiscal year in review: New drug approvals in the wake of the pandemic and legislative reforms

Agency IQ

BY AMANDA CONTI | OCT 4, 2023 10:40 PM CDT A quick note: How AgencyIQ gathers data on drug approvals AgencyIQ reviews drug approvals from the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). Featuring previous research by Kedest Tadesse, Kari Oakes and Alec Gaffney.

FDA 52
article thumbnail

Revealed: Disabled Marine Shows Men Over 40 How To Eliminate Weakness And Build Combat Ready Conditioning At Any Age…

The Pharma Data

I knew I needed to take my research “off-grid”, and…. …on At an unconventional strength seminar I tracked down a bear of a man known as “The Crazy Russian”… who exposed me to weird “mental tricks” to elevating your strength simply by changing the way you THINK about how your muscles move your body…. No one could give me answers, so….